Eris Lifesciences has reported results for third quarter ended December 31, 2022.
The company has reported fall of 4.49% in its net profit at Rs 99.38 crore for Q3FY23 as compared to Rs 104.06 crore for the corresponding quarter previous year. However, total income of the company increased by 8.06% to Rs 335.49 crore for the quarter as compared to Rs 310.47 crore for the same quarter in the previous year.
On the consolidated basis, the company has reported fall of 0.53% in its net profit at Rs 100.23 crore for Q3FY23 as compared to Rs 100.77 crore for the same quarter in the previous year. However, total income of the company increased by 26.13% to Rs 425.50 crore for the quarter under review as compared to Rs 337.34 crore for the same quarter in the previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1532.00 |
Dr. Reddys Lab | 5780.70 |
Cipla | 1442.00 |
Zydus Lifesciences | 1088.45 |
Lupin | 1683.50 |
View more.. |